These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [Antibacterial activity of antibiotics in experimental encephalitis. An indirect approach to the evaluation of the pharmacokinetic pattern]. Campanile F; Fioretti MC; Bonmassar E; Puccetti P G Ital Chemioter; 1985; 32(1):225-8. PubMed ID: 3830783 [No Abstract] [Full Text] [Related]
43. Current status of Pseudomonas infections and antibiotics. Norrby R Scand J Infect Dis Suppl; 1981; 29():81-6. PubMed ID: 6274001 [No Abstract] [Full Text] [Related]
44. The emergence of resistance to beta-lactam antibiotics during treatment of Pseudomonas aeruginosa lower respiratory tract infections: is combination therapy the solution? Nichols L; Maki DG Chemioterapia; 1985 Feb; 4(1):102-9. PubMed ID: 3986938 [TBL] [Abstract][Full Text] [Related]
45. Efficacy and pharmacokinetics of tobramycin in patients with chronic urinary tract infections and various degrees of renal impairment. Westenfelder SR; Welling G; Madsen PO Infection; 1974; 2(2):76-9. PubMed ID: 4842961 [No Abstract] [Full Text] [Related]
46. [Clinical studies of fortimicin in surgical infections]. Hosoma S; Seiko R; Ito T Jpn J Antibiot; 1982 Jun; 35(6):1387-90. PubMed ID: 7131763 [TBL] [Abstract][Full Text] [Related]
48. [Clinical evaluation of micronomicin for the treatment of postoperative infections in cancer patients]. Ohmori K; Suzuki M; Endo S; Watanabe I; Endo S Jpn J Antibiot; 1983 Jul; 36(7):1593-8. PubMed ID: 6655802 [TBL] [Abstract][Full Text] [Related]
54. [Rational use of aminoglycoside antibiotics on the basis of pharnacokinetics and pharmacodynamics theory]. Shi Y; Li P Zhonghua Jie He He Hu Xi Za Zhi; 2012 Oct; 35(10):726-8. PubMed ID: 23289987 [No Abstract] [Full Text] [Related]
55. [New antibiotics ready to be used in medical practice?]. Marget W MMW Munch Med Wochenschr; 1979 Sep; 121(36):1131-2. PubMed ID: 114781 [No Abstract] [Full Text] [Related]
56. Prophylaxis of pyelonephritis by aminoglycosides accumulated in the kidney. Bille J; Glauser MP J Antimicrob Chemother; 1981 Jul; 8 Suppl A():115-9. PubMed ID: 7263558 [No Abstract] [Full Text] [Related]
57. Clinical efficacy of aminoglycosides: an example of balance between microbiology and pharmacology. Klastersky J J Antimicrob Chemother; 1981 Jul; 8 Suppl A():143-9. PubMed ID: 7263561 [No Abstract] [Full Text] [Related]
58. Aminoglycoside antibiotic interference with a urinary protein method. Meola JM; Brown HH Clin Chem; 1979 Jun; 25(6):1180-1. PubMed ID: 445806 [No Abstract] [Full Text] [Related]
59. Problems in getting new antimicrobials tested in the laboratory. Flournoy DJ Hosp Top; 1982; 60(2):8-9. PubMed ID: 10254499 [No Abstract] [Full Text] [Related]
60. Antibiotic G418, a new micrommomospora-produced aminglycoside with activity apainst protozoa and helminths: antiparasitic activity. Loebenberg D; Counels M; Waitz JA Antimicrob Agents Chemother; 1975 Jun; 7(6):811-5. PubMed ID: 1155922 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]